marijuana stock news

mCig, Inc. (MCIG)

 

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Jul 31, 2015 Apr 30, 2015 Jan 31, 2015 Oct 31, 2014
Total Revenue 369   66   88   249  
Cost of Revenue 242 208 28 117
Gross Profit 127   (142) 61   132  
Operating Expenses
Research Development – 37 – –
Selling General and Administrative 788 1,507 803 901
Non Recurring – – – –
Others 2 1 2 2
Total Operating Expenses – – – –
Operating Income or Loss (663) (1,687) (744) (771)
Income from Continuing Operations
Total Other Income/Expenses Net – (639) – –
Earnings Before Interest And Taxes (663) (2,326) (744) (771)
Interest Expense – – – –
Income Before Tax (663) (2,326) (744) (771)
Income Tax Expense – – – –
Minority Interest – – – –
Net Income From Continuing Ops (663) (2,326) (744) (771)
Non-recurring Events
Discontinued Operations – 36 – (8)
Extraordinary Items – – – –
Effect Of Accounting Changes – – – –
Other Items – – – –
Net Income (663) (2,290) (744) (779)
Preferred Stock And Other Adjustments – – – –
Net Income Applicable To Common Shares (663) (2,290) (744) (779)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$CANV Awarded Sixth Cannabis Cup Award for Highest CBD Concentrate

CannaVest Corp. Garners Industry Record Sixth Cannabis Cup Award for Highest Cannabidiol…

Aurora Cannabis Inc. (ACBFF) Retains KCSA Strategic Communications to Enhance U.S. investor and Media Outreach

Aurora Cannabis Retains KCSA Strategic Communications to Enhance U.S. investor and Media…

Cresco Labs (CRLBF) Launches Social Justice Campaign on 50th Anniversary of War on Drugs

Cresco Labs Launches Social Justice Campaign on 50th Anniversary of War on…

INSYS Therapeutics, Inc. (INSY) to Present Poster of Pharmacokinetic Study of Naloxone Novel Nasal Spray

INSYS Therapeutics to Present Poster of Pharmacokinetic Study of Naloxone Novel Nasal…